Holen Sie sich die Stockscreener-App
14.36
11.69%
1.31
Schlusskurs vom Vortag:
$13.05
Offen:
$14.61
24-Stunden-Volumen:
17,095
Relative Volume:
0.33
Marktkapitalisierung:
$294.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-0.4793
EPS:
-29.96
Netto-Cashflow:
-
1W Leistung:
+11.17%
1M Leistung:
+18.98%
6M Leistung:
-2.83%
1J Leistung:
+1,057%
1-Tages-Spanne:
$14.29
$14.92
1-Wochen-Bereich:
$12.67
$14.92
52-Wochen-Spanne:
$10.92
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
Firmenname
Shoulder Innovations Inc
Sektor
Branche
Telefon
616-566-0286
Adresse
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
14.29 | 275.86M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
110.19 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
357.80 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
90.08 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
70.05 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.50 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | BTIG Research | Buy |
| 2025-08-25 | Eingeleitet | Goldman | Buy |
| 2025-08-25 | Eingeleitet | Jefferies | Buy |
| 2025-08-25 | Eingeleitet | Piper Sandler | Overweight |
| 2023-03-06 | Herabstufung | Compass Point | Neutral → Sell |
| 2023-03-06 | Herabstufung | Wedbush | Neutral → Underperform |
| 2023-03-02 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | Herabstufung | Compass Point | Buy → Neutral |
| 2023-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-03-01 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-01-06 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-01-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-12 | Bestätigt | Wedbush | Outperform |
| 2022-12-05 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-10-26 | Herabstufung | Goldman | Buy → Neutral |
| 2022-10-06 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | Eingeleitet | BTIG Research | Buy |
| 2022-06-13 | Eingeleitet | Wells Fargo | Overweight |
| 2022-06-09 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-03-21 | Eingeleitet | BofA Securities | Buy |
| 2022-01-20 | Hochstufung | Goldman | Neutral → Buy |
| 2021-12-16 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-11-08 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-06-14 | Eingeleitet | Goldman | Neutral |
| 2021-01-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-12-22 | Eingeleitet | Wedbush | Outperform |
| 2020-12-17 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | Eingeleitet | Craig Hallum | Buy |
| 2020-10-16 | Eingeleitet | Compass Point | Buy |
| 2020-03-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | Eingeleitet | Barclays | Overweight |
| 2019-11-18 | Eingeleitet | Compass Point | Buy |
Alle ansehen
Shoulder Innovations Inc Aktie (SI) Neueste Nachrichten
Shoulder Innovations revenue up 65% to USD 14.4M in Q4 2025 - Medical Buyer
BTIG raises Shoulder Innovations stock price target on revenue beat - Investing.com
Shoulder Innovations Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Shoulder Innovations reports strong Q4 2025 growth - Investing.com
Shoulder Innovations Reports Transformational 2025 Growth and Guidance - TipRanks
AAR to announce third quarter fiscal year 2026 results on March 24, 2026 - Weekly Voice
SHOULDER INNOVATIONS ($SI) Releases Q4 2025 Earnings - Quiver Quantitative
Shoulder Innovations (NYSE: SI) 2025 revenue jumps 50% as losses widen - Stock Titan
Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
Shoulder Innovations Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Director Andrew Hykes files Form 3 at Shoulder Innovations (SI) - Stock Titan
Shoulder Innovations, Inc. (NYSE:SI) Short Interest Update - MarketBeat
SI: AI-driven planning, innovative implants, and robotics fuel rapid growth in shoulder arthroplasty - TradingView
Shoulder Innovations adds Drew Hykes to board of directors By Investing.com - Investing.com South Africa
Shoulder Innovations adds Drew Hykes to board of directors - Investing.com
Shoulder Innovations Adds Medtech Veteran Drew Hykes to Board - TipRanks
Medtech leader Drew Hykes joins Shoulder Innovations (NYSE: SI) board after Pardo exit - Stock Titan
Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors - Nasdaq
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Senseonics Holdings (SENS) and Novo Nordisk (NVO) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Charles River Labs (CRL) and Warby Parker (WRBY) - The Globe and Mail
Shoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference - The Malaysian Reserve
Shoulder Innovations, Inc. (NYSE:SI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
TimesSquare Capital Management LLC Takes Position in Shoulder Innovations, Inc. $SI - MarketBeat
Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - BioSpace
Critical Survey: Biosig Technologies (NASDAQ:STEX) and Shoulder Innovations (NYSE:SI) - Defense World
Analysts Conflicted on These Healthcare Names: Align Tech (ALGN) and Boston Scientific (BSX) - The Globe and Mail
Is Shoulder Innovations (NYSE:SI) Weighed On By Its Debt Load? - simplywall.st
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), GE Healthcare Technologies Inc (GEHC) and Merck & Company (MRK) - The Globe and Mail
Federated Hermes Inc. Acquires Shares of 200,000 Shoulder Innovations, Inc. $SI - MarketBeat
Shoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - BioSpace
With 38% stake, Shoulder Innovations, Inc. (NYSE:SI) seems to have captured institutional investors' interest - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Soleno Therapeutics (SLNO) - The Globe and Mail
Analysts Offer Predictions for HOFT Q1 Earnings - Defense World
Jardine Matheson (LON:JAR) Sets New 52-Week High – Should You Buy? - Defense World
Shoulder Innovations, Inc. (NYSE:SI) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Rob Ball | Crain’s Newsmakers 2025 - Crain's Grand Rapids Business
D. Boral ARC Acquisition I Corp.’s Lock-Up Period Will Expire on January 27th (NASDAQ:BCARU) - Defense World
Shoulder Innovations, Inc.'s (NYSE:SI) Lock-Up Period To End on January 27th - MarketBeat
LPCVU’s Quiet Period To End on January 27th (NASDAQ:LPCVU) - Defense World
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Penumbra (PEN) - The Globe and Mail
Critical Contrast: Perspective Therapeutics (NASDAQ:CATX) and Shoulder Innovations (NYSE:SI) - Defense World
Impulse Dynamics® Announces New Chief Financial Officer - The Manila Times
Impulse Dynamics - Via Ritzau
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Insider Trends: How cyclical is Shoulder Innovations Inc stock compared to rivalsPrice Action & Fast Momentum Stock Entry Tips - moha.gov.vn
SI SEC FilingsShoulder Innovations, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net
Shoulder Innovations price target raised to $20 from $19 at Goldman Sachs - TipRanks
Shoulder Innovations (SI) CFO buys 1,076 ESPP shares, now holds 55,521 directly - Stock Titan
Shoulder Innovations (SI) officer adds 1,041 ESPP shares - Stock Titan
Shoulder Innovations (SI) CEO Robert Ball acquires ESPP shares, now holds 120,118 - Stock Titan
[Form 4] SHOULDER INNOVATIONS, INC. Insider Trading Activity - Stock Titan
Finanzdaten der Shoulder Innovations Inc-Aktie (SI)
Es liegen keine Finanzdaten für Shoulder Innovations Inc (SI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):